Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent has signed an agreement with ViralClear to work on the development of a potential treatment for adults with advanced COVID-19.
read more
Ardena has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
read more
Tuesday, October 27, 2020
Stevanato has expanded its collaboration with Catalent to include the provision and accelerated delivery of advanced visual inspection systems to help with potential solutions to the pandemic.
read more
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based pharmaceutical company, today announced that Jason Grenfell-Gardner has been appointed President and Chief Executive Officer of IGI Laboratories, Inc. effective July 30, 2012.
read more
Celerion is pleased to announce the expansion of clinical operations to South
Korea. Through partnership with Seoul National University Hospital (SNUH), the new Asian office is located
within the SNUH Clinical Trials Center. This enables Celerion ...
read more
Bay Area Research Logistics (BARL), a clinical trial services company announced its physical expansion into the US market with the opening of a new depot in New York State. BARL has been providing clinical supply services since 2007 for all phases of...
read more
Tuesday, January 14, 2025
Alcami Corporation announced the resignation of Bill Humphries. Alcami’s Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from ...
read more
Tuesday, October 07, 2014
Leading research peptide manufacturer [2]Cambridge Research Biochemicals (CRB) announced today that it has signed a non-exclusive license with The Scripps Research Institute (TSRI) to add click chemistry services, namely the “click” labelling of ...
read more
SRI International announced a research agreement with Ionis, combining SRI's proprietary FOX Three Molecular Guidance cellular targeting system with Ionis' proprietary antisense drug-discovery platform.
read more
Monday, February 03, 2020
During Q4 2019, Avara’s Liscate facility hosted the FDA as part of a Pre-Approval Inspection for a new Client’s product to be manufactured in the Small Volume Parenterals department.
read more
Monday, November 15, 2021
Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and accelerate clinical development, today announces the opening of its US headquarters in Boston, Massachusetts as part of the company’s ...
read more
Wednesday, January 13, 2021
bluebird bio announced its intent to separate its severe genetic disease and oncology businesses into differentiated and independent publicly traded companies.
read more
Wednesday, March 23, 2022
Shenandoah Biotechnology is a privately held company located in Warminster, Pennsylvania, that manufactures recombinant proteins including cytokines and growth factors. Shenandoah Biotechnology recently launched their CTG Grade™ line of cytokines and...
read more
ImprimisRx has agreed to a product supply agreement with EyeCare Services Partners (ESP).
read more
ClinTec International continues to deliver strong growth and further international expansion with the opening of two new offices in Spain, alongside the appointment of Carlos Palacios as the company’s new Regional Manager for Spain and Portugal.
read more